To view this email as a web page, click here.
 
Overdoses on the rise for this antidiarrheal drug
Overdoses on the rise for this antidiarrheal drug.
Read more
 
Pharma exec: new type 2 diabetes treatment competitively priced
How the first oral GLP-1 treatment for type 2 diabetes is unique, and how it will be priced compared to other GLP-1 medications.
Read more
 
Trump considers next FDA Commissioner
Health groups urge Trump to appoint Acting FDA Commissioner Ned Sharpless.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.